Biotabs Lifesciences Private Limited, a active private limited company, was established on 12 December 2012 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U85100TN2012PTC088940. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Nachiappan Manimuthu (Director), Thilagavathi Durairaj (Director), Vadivel Durairaj (Director). Past directors included Kumar Pillai Karuppa, Saravanan, Kadar Basha Mohammed Irfan. It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 48B, Adinath Avenue, Vengaivasal, Chennai, Tamil Nadu, 600073.
U85100TN2012PTC088940
088940
12 December 2012
₹5.00 M
₹5.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Biotabs Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nachiappan Manimuthu | Director | 24 Jun 2015 | Current |
| Thilagavathi Durairaj | Director | 15 Jan 2024 | Current |
| Vadivel Durairaj | Director | 06 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2014 | Past |
| Pramod Abcsdd | Director | 10 Jan 2024 | Past |
| Pramod Abcsdd | Director | 10 Jul 2015 | Past |
| Pramod Abcsdd | Director | 01 Mar 2022 | Past |
| Pramod Abcsdd | Director | 06 Mar 2025 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biotabs Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.44% increase. The company also saw a substantial fall in profitability, with a 148.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 48.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Biotabs Lifesciences had a promoter holding of 65.13% and a public holding of 34.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2019 | Others | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biotabs Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biotabs Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotabs Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vadivel Durairaj was appointed as a Director was appointed as a Director on 06 Mar 2025 & has been associated with this company since 8 months 28 days . was recorded as a recent event.
Progress on Biotabs Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Biotabs Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on Thilagavathi Durairaj was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Progress on A charge with Others amounted to Rs. 1.20 M with Charge ID 100309890 was registered on 01 Nov 2019. was documented.
The activity Nachiappan Manimuthu was appointed as a Director was appointed as a Director on 24 Jun 2015 & has been associated with this company since 10 years 5 months . was completed.
The CIN of Biotabs Lifesciences Private Limited is U85100TN2012PTC088940.
Biotabs Lifesciences Private Limited is headquartered at 48B, Adinath Avenue, Vengaivasal, Chennai, Tamil Nadu, 600073.
Biotabs Lifesciences Private Limited was incorporated on 12 December 2012.
The current directors of Biotabs Lifesciences Private Limited are
The primary industry of Biotabs Lifesciences Private Limited is Trade.
Biotabs Lifesciences Private Limited is unlisted.
The authorized capital of Biotabs Lifesciences Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Biotabs Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX